about
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactu...
Read More
1.13
0.22
(24.18%)
26.0M
XNAS Volume
High volume+gain today
XNAS 13 May, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Humacyte Inc took place on 13 May 2026, for the purpose of Humacyte Inc First Quarter Earnings Result for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Humacyte Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..